Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Feili-Hariri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Immunology|November 13, 2001
How do dendritic cells prevent autoimmunity?P A Morel, M Feili-Hariri
Clinical Immunology (Orlando, Fla.)|January 6, 2001
Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strainsM Feili-Hariri, P A Morel
Journal of Autoimmunity|March 24, 2000
Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptideM Feili-Hariri, M O Frantz, P A Morel
Journal of Leukocyte Biology|August 17, 1999
Immunobiology of DC in NOD miceP A Morel, A C Vasquez, M Feili-Hariri
International Immunology|December 1, 1996
Functional consequences of the binding of MHC class II-derived peptides to MHC class IIM Feili-Hariri, H Kao, T A Mietzner, et al.
Clinical and Experimental Immunology|June 26, 2003
Dendritic cells, T cell tolerance and therapy of adverse immune reactionsP A Morel, M Feili-Hariri, P T Coates, et al.
Clinical and Experimental Immunology|January 24, 2004
Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD miceA C Vasquez, M Feili-Hariri, R J Tan, et al.
Magnetic Resonance in Medicine|May 28, 2003
Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imagingE T Ahrens, M Feili-Hariri, H Xu, et al.
Diabetes|December 2, 1999
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsM Feili-Hariri, X Dong, S M Alber, et al.
Transplantation Proceedings|March 31, 2009
Dendritic cell therapy in composite tissue allotransplantationA W Thomson, J M Sacks, Y-R Kuo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Immunology|November 13, 2001
How do dendritic cells prevent autoimmunity?P A Morel, M Feili-Hariri
Clinical Immunology (Orlando, Fla.)|January 6, 2001
Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strainsM Feili-Hariri, P A Morel
Journal of Autoimmunity|March 24, 2000
Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptideM Feili-Hariri, M O Frantz, P A Morel
Journal of Leukocyte Biology|August 17, 1999
Immunobiology of DC in NOD miceP A Morel, A C Vasquez, M Feili-Hariri
International Immunology|December 1, 1996
Functional consequences of the binding of MHC class II-derived peptides to MHC class IIM Feili-Hariri, H Kao, T A Mietzner, et al.
Clinical and Experimental Immunology|June 26, 2003
Dendritic cells, T cell tolerance and therapy of adverse immune reactionsP A Morel, M Feili-Hariri, P T Coates, et al.
Clinical and Experimental Immunology|January 24, 2004
Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD miceA C Vasquez, M Feili-Hariri, R J Tan, et al.
Magnetic Resonance in Medicine|May 28, 2003
Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imagingE T Ahrens, M Feili-Hariri, H Xu, et al.
Diabetes|December 2, 1999
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsM Feili-Hariri, X Dong, S M Alber, et al.
Transplantation Proceedings|March 31, 2009
Dendritic cell therapy in composite tissue allotransplantationA W Thomson, J M Sacks, Y-R Kuo, et al.
Pageof 1